P1015: DURATION OF TREATMENT AND REDUCTION IN SERUM TRYPTASE LEVELS IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY

ABSTRACT:

SUBMITTER: Reiter A 

PROVIDER: S-EPMC9429120 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature